A description of risk factors for mortality in adults with end-stage chronic kidney disease

• Autores: Alvis-Peña, Diego, Calderon-Franco, Carlos, Calderón-Franco, Carlos
• Formato: artículo
• Fecha de Publicación: 2020
• Institución: Colegio Médico del Perú
• Repositorio: Acta Médica Peruana
• Lenguaje: español
• OAI Identifier: oai:amp.cmp.org.pe:article/980
• Enlace del recurso: https://amp.cmp.org.pe/index.php/AMP/article/view/980
• Nivel de acceso: acceso abierto
• Materia: Insuficiencia renal crónica; Fallo renal crónico; Terapia de reemplazo renal; Diálisis renal; Diálisis peritoneal; Renal insufficiency, chronic; Kidney failure, chronic; Renal replacement therapy; Renal dialysis; Peritoneal dialysis

Objective: to describe both clinical and demographic characteristics of patients with end-stage kidney disease (ESKD) and the association of such variables with mortality. Materials and methods: this is an observational, descriptive, and cross-sectional study with an analytical approach, which was performed in the nephrology service of a private HMO in Florencia-Caqueta. We studied socio-demographic and clinical variables using univariate and bivariate analyses, applying an association test with mortality using the Chi-square test and simple logistic regression, aiming to calculate prevalence rates (PR). Results: twohundred and thirteen patients were assessed, their average age was 60.0 ± 1.4 years; 48.3% were female, and the recorded mortality rate was 29.3%. Factors associated with mortality were as follows: LDL-C <70 mg/dL (PR: 0.45, 95% CI: 0.24–0.84) and serum albumin <3.5 g/dL (PR: 12.65; 95% CI: 5.85–27.3). Conclusion: hypoalbuminemia and low LDL-C levels are associated with mortality in patients with ESKD in Florencia-Caqueta. Hypoalbuminemia is considered as a risk factor, while LDL levels <70 mg/dL are considered as a protective factor.